Heart Monitor from AliveCor Receives Clearance from FDA
Published By : 27 Aug 2014 | Published By : QYRESEARCH
AliveCor Incorporated announced that the United States Food and Drug Administration (USFDA) granted the company clearance for the algorithm use to detect AFib (atrial fibrillation).
Atrial fibrillation is the most common type of cardiac arrhythmia. The automated analysis process or algorithm from AliveCor instantly detects if a patient is experiencing atrial fibrillation using real time electrocardiogram recording recorded on the mobile phone based AliveCor Heart Monitor.
This aids physicians to intervene in the situation before potentially life-threatening disorders like strokes take place. Using AliveCor electrocardiogram analysis service, patients can confirm the results with a certified cardiologist or with their personal physician.
According to the president and CEO of AliveCor, the ability to detect serious heart arrhythmia automatically using mobile technology possess a potential to save many lives and lower the healthcare cost which will allow patients and caregivers to decide about cardiac care in an informed manner. He further added that by achieving clearance for the device, they will work to incorporate their algorithm in their app and make it available in the market during the month of September.
The heart monitor from AliveCor is aimed to record, store, and transfer ECG rhythms. The monitor also video displays ECG rhythms, along with the atrial fibrillation as and when prescribed by a physician. This heart monitor is intended for healthcare professionals use who have patients they suspect of heart condition. It is intended for use by health conscious people as well.
The AliveCor Heart Monitor is mobile compatible with most Android and all iPhone models. The app will allow the users to access their healthcare data anytime and anywhere.